Syndax Pharmaceuticals Inc - Common Stock (SNDX)
CUSIP: 87164F105
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 86,727,396
- Total 13F shares
- 32,648,161
- Share change
- +11,861,972
- Total reported value
- $483,839,331
- Put/Call ratio
- 22%
- Price per share
- $14.82
- Number of holders
- 96
- Value change
- +$177,178,450
- Number of buys
- 74
- Number of sells
- 25
Quarterly Holders Quick Answers
What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87164F105:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.5%
|
2,999,629
|
$32,907,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.8%
|
2,408,235
|
$26,418,000 | — | 31 Mar 2020 | |
| MPM ASSET MANAGEMENT LLC |
13F
|
Company |
2.5%
|
2,168,691
|
$23,791,000 | — | 31 Mar 2020 | |
| BVF INC/IL |
13F
|
Company |
2.5%
|
2,139,784
|
$23,473,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
1,078,728
|
$11,834,000 | — | 31 Mar 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.2%
|
1,000,000
|
$10,970,000 | — | 31 Mar 2020 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
1.1%
|
990,711
|
$10,868,000 | — | 31 Mar 2020 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.1%
|
933,038
|
$10,235,000 | — | 31 Mar 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1%
|
888,516
|
$9,746,000 | — | 31 Mar 2020 | |
| Aisling Capital Management LP |
13F
|
Company |
1%
|
875,000
|
$9,599,000 | — | 31 Mar 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
0.84%
|
725,782
|
$7,962,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.56%
|
487,600
|
$5,349,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.51%
|
439,902
|
$4,826,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
333,258
|
$3,655,000 | — | 31 Mar 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.33%
|
290,000
|
$3,181,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.32%
|
281,091
|
$3,084,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
275,615
|
$3,024,000 | — | 31 Mar 2020 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.29%
|
250,000
|
$2,743,000 | — | 31 Mar 2020 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
226,680
|
$2,487,000 | — | 31 Mar 2020 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.21%
|
180,000
|
$1,975,000 | — | 31 Mar 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.16%
|
134,449
|
$1,472,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
82,587
|
$906,000 | — | 31 Mar 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.09%
|
81,248
|
$891,000 | — | 31 Mar 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
79,000
|
$867,000 | — | 31 Mar 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.09%
|
77,573
|
$851,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.09%
|
75,037
|
$824,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
70,764
|
$776,000 | — | 31 Mar 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
69,475
|
$761,000 | — | 31 Mar 2020 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.08%
|
68,134
|
$747,000 | — | 31 Mar 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
0.08%
|
66,100
|
$725,000 | — | 31 Mar 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.07%
|
64,805
|
$711,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.07%
|
61,259
|
$672,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.07%
|
60,152
|
$660,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
55,758
|
$612,000 | — | 31 Mar 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.06%
|
53,265
|
$584,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.06%
|
51,552
|
$566,000 | — | 31 Mar 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.04%
|
36,700
|
$403,000 | — | 31 Mar 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
34,027
|
$373,000 | — | 31 Mar 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
32,356
|
$355,000 | — | 31 Mar 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.04%
|
31,800
|
$349,000 | — | 31 Mar 2020 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
29,720
|
$326,000 | — | 31 Mar 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
28,300
|
$310,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
26,899
|
$295,000 | — | 31 Mar 2020 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.03%
|
25,308
|
$278,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
24,625
|
$270,000 | — | 31 Mar 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
23,474
|
$258,000 | — | 31 Mar 2020 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.03%
|
22,580
|
$248,000 | — | 31 Mar 2020 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.02%
|
20,980
|
$230,000 | — | 31 Mar 2020 | |
| CAXTON ASSOCIATES LP |
13F
|
Company |
0.02%
|
20,326
|
$223,000 | — | 31 Mar 2020 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.02%
|
20,046
|
$219,000 | — | 31 Mar 2020 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q2 2020
As of 30 Jun 2020,
Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,648,161 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, BOXER CAPITAL, LLC, MPM ASSET MANAGEMENT LLC, BlackRock Inc., Avidity Partners Management LP, VANGUARD GROUP INC, FRAZIER MANAGEMENT LLC, ORBIMED ADVISORS LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
96
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
81
Q2 2020 holders
96
Holder diff
15
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.